FR2598319B1 - Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation - Google Patents

Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation

Info

Publication number
FR2598319B1
FR2598319B1 FR878706454A FR8706454A FR2598319B1 FR 2598319 B1 FR2598319 B1 FR 2598319B1 FR 878706454 A FR878706454 A FR 878706454A FR 8706454 A FR8706454 A FR 8706454A FR 2598319 B1 FR2598319 B1 FR 2598319B1
Authority
FR
France
Prior art keywords
delivery
media
dosage form
medicinal composition
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878706454A
Other languages
English (en)
French (fr)
Other versions
FR2598319A1 (fr
Inventor
Atul Devdatt Ayer
Felix Theeuwes
Patrick S-L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2598319A1 publication Critical patent/FR2598319A1/fr
Application granted granted Critical
Publication of FR2598319B1 publication Critical patent/FR2598319B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR878706454A 1986-05-09 1987-05-07 Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation Expired FR2598319B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/861,188 US4842867A (en) 1986-05-09 1986-05-09 Pulsed drug delivery of doxylamine

Publications (2)

Publication Number Publication Date
FR2598319A1 FR2598319A1 (fr) 1987-11-13
FR2598319B1 true FR2598319B1 (fr) 1989-12-01

Family

ID=25335124

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878706454A Expired FR2598319B1 (fr) 1986-05-09 1987-05-07 Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation

Country Status (14)

Country Link
US (1) US4842867A (enExample)
JP (2) JPS62298529A (enExample)
KR (1) KR950010144B1 (enExample)
AU (1) AU621030B2 (enExample)
BE (1) BE1000232A5 (enExample)
CA (1) CA1297368C (enExample)
CH (1) CH671696A5 (enExample)
DE (1) DE3715224C2 (enExample)
ES (1) ES2005571A6 (enExample)
FR (1) FR2598319B1 (enExample)
IT (1) IT1208883B (enExample)
NL (1) NL193308C (enExample)
SE (1) SE502684C2 (enExample)
ZA (1) ZA873091B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029416B2 (en) 1996-11-12 2015-05-12 Alza Corporation Methods and devices for providing prolonged drug therapy
US9393192B2 (en) 2002-07-29 2016-07-19 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone and risperidone

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141752A (en) * 1986-05-09 1992-08-25 Alza Corporation Delayed drug delivery device
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL88083A (en) * 1987-11-06 1992-11-15 Tanabe Seiyaku Co Controlled release pharmaceutical dosage form and its preparation
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5456679A (en) * 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) * 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
US5209746A (en) * 1992-02-18 1993-05-11 Alza Corporation Osmotically driven delivery devices with pulsatile effect
US5221278A (en) * 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
EP0652745A1 (en) * 1992-07-31 1995-05-17 Daratech Pty. Ltd. Controlled release implants
US5391378A (en) * 1993-02-22 1995-02-21 Elizabeth-Hata International, Inc. Two-part medicinal tablet and method of manufacture
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5718700A (en) * 1994-09-20 1998-02-17 Alza Corporation Exit means in dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
JP4393587B2 (ja) * 1996-08-16 2010-01-06 アルザ コーポレイション 医薬の上昇性投与量を提供するための薬剤投与型
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
US6372254B1 (en) * 1998-04-02 2002-04-16 Impax Pharmaceuticals Inc. Press coated, pulsatile drug delivery system suitable for oral administration
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
CN1227003C (zh) * 1998-09-09 2005-11-16 阿尔萨公司 包括液体制剂的剂型
HUP0104993A3 (en) * 1998-11-02 2003-02-28 Alza Corp Mountain View Method and device for controlled delivery of active agents
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
JP5005157B2 (ja) * 2001-03-13 2012-08-22 ペンウェスト ファーマシューティカルズ カンパニー 時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
EP1492509A1 (en) * 2001-12-18 2005-01-05 ALZA Corporation Dosage form providing time-varying patterns of drug delivery
CN1606434A (zh) * 2001-12-19 2005-04-13 株式会社三和化学研究所 控制释放成型品
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
EP1539270A1 (en) * 2002-09-18 2005-06-15 Medtronic Vascular, Inc. Controllable drug releasing gradient coatings for medical devices
US20040091538A1 (en) * 2002-10-31 2004-05-13 Crystal Pollock-Dove Dosage form providing ascending release of liquid formulation
CA2539182A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
WO2005027878A1 (en) * 2003-09-19 2005-03-31 Penwest Pharmaceuticals Co. Delayed released dosage forms
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
CN107033368A (zh) 2009-11-09 2017-08-11 聚光灯技术合伙有限责任公司 碎裂水凝胶
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
WO2013123569A1 (en) * 2012-02-22 2013-08-29 Duchesnay Inc. Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
BR112014020186A8 (pt) 2012-02-22 2017-07-11 Duchesnay Inc Formulação de doxilamina e piridoxina e/ou seus metabólitos ou sais
HUE039131T2 (hu) 2013-07-22 2018-12-28 Duchesnay Inc Hányinger és hányás kezelésére szolgáló készítmény
US9452181B2 (en) 2013-07-22 2016-09-27 Duchesnay Inc. Composition for the management of nausea and vomiting
TWI595874B (zh) 2014-08-29 2017-08-21 達契斯奈股份有限公司 多西拉敏及吡哆醇及／或其代謝產物或鹽之多模式釋放調配物
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
JP6878417B2 (ja) * 2016-02-17 2021-05-26 トリアステック インコーポレイテッド 剤形およびそれらの使用
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4298003A (en) * 1980-05-12 1981-11-03 Alza Corporation System for delivering agent at zero order rate with emerging agent below saturation
US4439196A (en) * 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
GB2155889B (en) * 1984-03-21 1988-03-02 Alza Corp Dispenser-capsule
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9029416B2 (en) 1996-11-12 2015-05-12 Alza Corporation Methods and devices for providing prolonged drug therapy
US9144549B2 (en) 1996-11-12 2015-09-29 Alza Corporation Methods and devices for providing prolonged drug therapy
US9393192B2 (en) 2002-07-29 2016-07-19 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone and risperidone

Also Published As

Publication number Publication date
JPS62298529A (ja) 1987-12-25
IT8767393A0 (it) 1987-05-07
NL193308B (nl) 1999-02-01
CA1297368C (en) 1992-03-17
SE8701900L (sv) 1987-11-10
DE3715224C2 (de) 1997-02-20
SE8701900D0 (sv) 1987-05-08
JPS62267221A (ja) 1987-11-19
CH671696A5 (enExample) 1989-09-29
ZA873091B (en) 1987-12-30
KR870010866A (ko) 1987-12-18
AU621030B2 (en) 1992-03-05
US4842867A (en) 1989-06-27
SE502684C2 (sv) 1995-12-11
FR2598319A1 (fr) 1987-11-13
NL193308C (nl) 1999-06-02
AU7183787A (en) 1987-11-12
KR950010144B1 (ko) 1995-09-11
DE3715224A1 (de) 1987-11-12
ES2005571A6 (es) 1989-03-16
IT1208883B (it) 1989-07-10
BE1000232A5 (fr) 1988-09-20
JPH07116018B2 (ja) 1995-12-13
NL8701102A (nl) 1987-12-01

Similar Documents

Publication Publication Date Title
FR2598319B1 (fr) Forme posologique pour delivrer une composition de medicament a un milieu d'utilisation
BE893394A (fr) Bandage pour l'administration d'une substance pharmaceutique
FR2565829B1 (fr) Dispositif pour l'administration des medicaments sous forme de poudres
BE849632A (fr) Composition pharmaceutique pour l'administration orale
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
FR2550452B1 (fr) Dispositif pour administrer des medicaments a des patients
IT8248908A0 (it) Composizione farmaceutica per la somministrazione per via orale dicomposti che debbono essere assorbiti nell'intestino crasso
FR2585563B1 (fr) Dispositif pour administrer des medicaments a des patients
IT8521291V0 (it) Dispositivo distributore a perdere per distribuire quantita'successive predeterminate di un farmaco.
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
IT1197038B (it) Composizione farmaceutica ad attivita' analgesica
FR2518410B1 (fr) Appareil d'injection sous pression pour actionner une seringue
BE893193A (fr) Composition pharmaceutique contenant du 24-25-dihydroxy-cholecalciferol a titre d'ingredient actif
IE860785L (en) Composition for delivery of orally administered drugs
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
FR2480603B1 (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
IL84659A (en) Pharmaceutical composition for delivery of azumolene directly to intestines
FR2570602B1 (fr) Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
FR2598079B1 (fr) Forme de dosage pour un meilleur apport de substances a un milieu
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
FR2505647B1 (fr) Dispositif pour l'injection sous pression d'agents d'entretien se trouvant dans des pieces a main medicales, notamment de dentisterie
FR2623089B1 (fr) Composition pharmaceutique pour l'administration parenterale de navelbine
FR2512342B1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose